UMHAT Pulmed OOD

Plovdiv 4002

2 studies enrolling now · 7 studies all time

What they study most

Lupus Erythematosus, Systemic, Primary Sjogrens Disease, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis

Studies at this site

• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Enrolling by invitation
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• A Phase II Study of M2951 in SLE — Stopped early